Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease

Neurobiology of Disease

Volumn 22, Issue 2, 2006, Pages 421-434

  Chaturvedi, R K ^a   Shukla, S ^a   Seth, K ^a   Chauhan, S ^b   Sinha, C ^a   Shukla, Y ^a   Agrawal, A K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

Black tea; Neurodegeneration; Neuroprotection; Neurorescue; Parkinson's disease; Polyphenols

Indexed keywords

CATALASE; DEXAMPHETAMINE; GLUTATHIONE; MESSENGER RNA; OXIDOPAMINE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR; BRAIN DAMAGE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FEMALE; IMMUNOREACTIVITY; LIPID PEROXIDATION; LOCOMOTION; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; STRIATE CORTEX; SUBSTANTIA NIGRA; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; BRAIN; CELL SURVIVAL; CORPUS STRIATUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOPAMINE; DYSKINESIAS; FEMALE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PLANT EXTRACTS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; TEA; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE;

EID: 33646137778     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.12.008     Document Type: Article

References (82)

1. Agrawal A.K., Squib R.E., and Bondy S.C. Effect of acrylamide treatment upon dopamine receptor binding. Toxicol. Appl. Pharmacol. 58 (1981) 89-99
2. Agrawal A.K., Husain R., Raghubir R., Kumar A., and Seth P.K. Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats. Int. J. Dev. Neurosci. 13 (1995) 105-111
3. Agrawal A.K., Chaturvedi R.K., Shukla S., Seth K., Chauhan S., Ahmad A., and Seth P.K. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J. Chem. Neuroanat. 28 (2004) 253-264
4. Agrawal A.K., Shukla S., Chaturvedi R.K., Seth K., Srivastava N., Ahmad A., and Seth P.K. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol. Dis. 16 (2004) 516-526
5. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., Ishrat T., Chaturvedi R.K., Agrawal A.K., and Islam F. Ginko biloba affords dose dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioral, neurochemical and immunohistochemical evidences. J. Neurochem. 93 (2005) 94-104
6. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
7. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., and Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001) 135-172
8. Bohme D.H., Kosechi R., Carsen S., Stern F., and Marks N. Lipoperoxidation in human and rat brain tissue: developmental and regional studies. Brain Res. 136 (1977) 11-21
9. Carman L.S., Gage F.H., and Shults C.W. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553 (1991) 275-283
10. Chalimoniuk M., Stepien A., and Strosznajder J.B. Pergolide mesylate, a dopaminergic receptor agonist, applied with l-DOPA enhances serum antioxidant enzyme activity in Parkinson disease. Clin. Neuropharmacol. 27 (2004) 223-229
11. Chaturvedi R.K., Agrawal A.K., Seth K., Shukla S., Shukla Y., Sinha C., and Seth P.K. Effect of glial cell line derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 21 (2003) 391-400
12. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., and Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 155 (2002) 732-738
13. Chen C., Yu R., Owuor E.D., and Kong A.N. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharmacol. Res. 23 (2000) 605-612
14. Chen S., Xianwen C., Dehua X., Zhenguo L., Lingfei X., Smith S.W., and Zhongcheng Z. Behavioral correction of Parkinsonian rats following the transplantation of immortalized fibroblasts genetically modified with TH and GCH genes. Parkinsonism Relat. Disord. 2 (2003) S91-S97
15. Chung J.H., Han J.H., Hwang E.J., Seo J.Y., Cho K.H., Kim K.H., Youn J.I., and Eun H.C. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J. 17 (2003) 1913-1915
16. Dawson T.M., and Dawson V.L. Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat. Neurosci. 5 (2002) S1058-S1061
17. Dufresne C.J., and Farnworth E.R. A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem. 7 (2001) 404-421
18. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., and O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 7 (2001) 243-246
19. Fahn S., and Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 1 (2004) 139-154
20. Foster H.D., and Hoffer A. The two faces of l-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. Med. Hypotheses 62 (2004) 177-181
21. Frei B., and Higdon J.V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 133 (2003) S3275-S3284
22. Gerlach M., Double K.L., Ben-Shachar D., Zecca L., Youdim M.B., and Riederer P. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease. Neurotox. Res. 5 (2003) 35-44
23. Halder J., and Bhaduri A.N. Protective role of black tea against oxidative damage of human red blood cells. Biochem. Biophys. Res. Commun. 244 (1998) 903-907
24. Halder B., Pramanick S., Mukhopadhyay S., and Giri A.K. Inhibition of benzo[a]pyrene induced mutagenicity and genotoxicity by black tea polyphenols theaflavins and thearubigins in multiple test systems. Food Chem. Toxicol. 43 (2005) 591-597
25. Hellenbrand W., Boeing H., Robra B.P., Seidler A., Vieregge P., Nischan P., Joerg J., Oertel W.H., Schneider E., and Ulm G. Diet and Parkinson's disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47 (1996) 644-650
26. Higdon J.V., and Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43 (2003) 89-143
27. Hurrell R.F., Reddy M., and Cook J.D. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br. J. Nutr. 81 (1999) 289-295
28. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biol. Med. 30 (2001) 433-446
29. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 S3 (1996) S161-S170
30. Joghataie M.T., Roghani M., Negahdar F., and Hashemi L. Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence. Parkinsonism Relat. Disord. 10 (2004) 465-468
31. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophy. 21 (1984) 130-132
32. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152 (1998) 259-277
33. Komatsu M., and Hiramatsu M. The efficacy of an antioxidant cocktail on lipid peroxide level and superoxide dismutase activity in aged rat brain and DNA damage in iron-induced epileptogenic foci. Toxicology 148 (2000) 143-148
34. Kondo J.-i., Kitamura Y., Inden M., and Taniguchi T. Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins. International Congress Series 1260 (2004) 281-285
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Lambert J.D., Hong J., Yang G.Y., Liao J., and Yang C.S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81 (2005) S284-S291
37. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., and Yang C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans. Formation of different metabolites and individual variability. Cancer Epidemiol., Biomarkers Prev. 11 (2002) 1025-1032
38. Lee S.Y., Kim C.Y., Lee J.J., Jung J.G., and Lee S.R. Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res. Bull. 61 (2003) 399-406
39. Lee S.R., Im K.J., Suh S.I., and Jung J.G. Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytother. Res. 17 (2003) 206-209
40. Leung L.K., Su Y., Chen R., Zhang Z., Huang Y., and Chen Z.Y. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J. Nutr. 131 (2001) 2248-2251
41. Levites Y., Weinreb O., Maor G., Youdim M.B., and Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78 (2001) 1073-1082
42. Levites Y., Amit T., Youdim M.B., and Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277 (2002) 30574-30580
43. Levites Y., Amit T., Mandel S., and Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 17 (2003) 952-954
44. Lowry O.H., Rosenburg N.J., Farr A.L., and Randall R.J. Protein measurement by Folin phenol reagent. J. Biol. Chem. 193 (1951) 165-175
45. Lu H., Meng X., and Yang C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab. Dispos. 31 (2003) 572-579
46. Luczaj W., and Skrzydlewska E. Antioxidant properties of black tea in alcohol intoxication. Food Chem. Toxicol. 42 (2004) 2045-2051
47. Mandel S., and Youdim M.B. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radical Biol. Med. 37 (2004) 304-317
48. Mandel S., Reznichenko L., Amit T., and Youdim M.B. Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway. Neurotox. Res. 5 (2003) 419-424
49. Mattson M.P., Duan W., Chan S.L., Cheng A., Haughey N., Gary D.S., Guo Z., Lee J., and Furukawa K. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol. Aging 23 (2002) 695-705
50. Mercer L.D., Kelly B.L., Horne M.K., and Beart P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem. Pharmacol. 69 (2005) 339-345
51. Miller J.W. Homocysteine, folate deficiency, and Parkinson's disease. Nutr. Rev. 60 (2002) 410-413
52. Misra A., Chattopadhyay R., Banerjee S., Chattopadhyay D.J., and Chatterjee I.B. Black tea prevents cigarette smoke-induced oxidative damage of proteins in guinea pigs. J. Nutr. 133 (2003) 2622-2628
53. Nakagawa K., and Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol. (Tokyo) 43 (1997) 679-684
54. Nie G., Cao Y., and Zhao B. Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep. 7 (2002) 171-177
55. Oak M.H., El Bedoui J., and Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 16 (2005) 1-8
56. Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., and Lin J.K. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of kappa B kinase activity in macrophages. Biochem. Pharmacol. 59 (2000) 357-367
57. Paraskevas G.P., Kapaki E., Petropoulou O., Anagnostouli M., Vagenas V., and Papageorgiou C. Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism. J. Neurol. Sci. 215 (2003) 51-55
58. In: Paxinos G., and Watson C. (Eds). The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, California, USA
59. Rah D.K., Han D.W., Baek H.S., Hyon S.H., and Park J.C. Prevention of reactive oxygen species-induced oxidative stress in human microvascular endothelial cells by green tea polyphenol. Toxicol. Lett. 155 (2005) 269-275
60. Rechner A.R., Wagner E., Van Buren L., Van De Put F., Wiseman S., and Rice-Evans C.A. Black tea represents a major source of dietary phenolics among regular tea drinkers. Free Radical Res. 36 (2002) 1127-1135
61. Reznichenko L., Amit T., Youdim M.B.H., and Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J. Neurochem. 93 (2005) 1157-1167
62. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., and Youdim M.B. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52 (1989) 515-520
63. Roghani M., and Behzadi G. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Res. 892 (2001) 211-217
64. Sano M., Takahashi Y., Yoshino K., Shimoi K., Nakamura Y., Tomita I., Oguni I., and Konomoto H. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol. Pharm. Bull. 18 (1995) 1006-1008
65. Scatchard G. The alteration of protein for small molecules and ions. Ann. N. Y. Acad. Sci. 51 (1949) 660-672
66. Sedlak J., and Linsay R.H. Estimation of total protein bound and non-protein bound sulphydryl group in tissue with Ellman's reagents. Anal. Biochem. 25 (1968) 192-205
67. Shukla Y., and Taneja P. Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice. Cancers Lett. 176 (2002) 137-141
68. Shukla S., Agrawal A.K., Chaturvedi R.K., Seth K., Srivastava N., Sinha C., Shukla Y., Khanna V.K., and Seth P.K. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease. J. Neurochem. 91 (2004) 274-284
69. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394
70. Skrzydlewska E., Ostrowska J., Farbiszewski R., and Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 3 (2002) 232-238
71. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Munoz-Patino A.M., and Labandeira-Garcia J.L. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J. Neurochem. 74 (2000) 1605-1612
72. Steele V.E., Kelloff G.J., Balentine D., Boone C.W., Mehta R., Bagheri D., Sigman C.C., Zhu S., and Sharma S. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 21 (2000) 63-67
73. Sweeney M.I., Kalt W., MacKinnon S.L., Ashby J., and Gottschall-Pass K.T. Feeding rats diets enriched in lowbush blueberries for six weeks decreases ischemia-induced brain damage. Nutr. Neurosci. 5 (2002) 427-431
74. Taneja P., Arora A., and Shukla Y. Antimutagenic effects of black tea in the Salmonella typhimurium reverse mutation assay. Asian Pac. J. Cancer Prev. 4 (2003) 193-198
75. Tyurina Y.Y., Tyurin V.A., Carta G., Quinn P.J., Schor N.F., and Kagan V.E. Direct evidence for antioxidant effect of Bcl-2 in PC-12 rat pheochromocytoma cells. Arch. Biochem. Biophys. 344 (1997) 413-423
76. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. 367 (1971) 49-68
77. Vita J.A. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr. 81 (2005) S292-S297
78. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 22 (1999) 51-61
79. Yoshino K., Hara Y., Sano M., and Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol. Pharm. Bull. 17 (1994) 146-149
80. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Salim S., and Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J. Neurochem. 84 (2003) 438-446
81. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Saleem S., and Islam F. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J. Chem. Neuroanat. 26 (2003) 143-151
82. Zhu B.T. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. Int. J. Mol. Med. 13 (2004) 343-353